期刊文献+

细胞角蛋白-19 波形蛋白 血管内皮生长因子-C和环氧化物酶-2在甲状腺乳头状癌和滤泡癌中的表达及意义 被引量:4

Expression and Significance of Cytokeratin-19, Vimentin, Vascular Endothelial Growth Factor-C and Cyclooxygenase-2 in Papillary Carcinoma and Follicular Carcinoma of Thyroid
暂未订购
导出
摘要 目的:探讨细胞角蛋白-19(CK-19)、波形蛋白(Vimentin)、血管内皮生长因子-C(VEGF-C)和环氧化物酶-2(COX-2)表达与甲状腺乳头状癌和滤泡癌分化、浸润、转移的关系。方法:采用免疫组织化学SP法检测94例乳头状癌和54例滤泡癌中CK-19、Vimentin、VEGF-C、COX-2的表达。结果:CK-19、VEGF-C、COX-2表达于癌细胞的胞浆,Vimentin在癌组织的间质和癌细胞的胞浆均有表达,其表达差异从阳性率和阳性强度两个方面予以统计分析。乳头状癌中CK-19表达的阳性率(90.4%)高于滤泡癌(61.1%),Vimentin、VEGF-C和COX-2表达的阳性率(100%、86.2%、81.9%)近似于滤泡癌(100%、87.0%、81.5%)。乳头状癌无转移组和有转移组(含原发灶和转移灶)四种指标的阳性率均相近,滤泡癌高分化型组与低分化型组相比,除Vimentin的阳性率均为100%外,其他三种指标CK-19、VEGF-C、COX-2均为高分化型组阳性率(74.1%、88.9%和85.2%),高于低分化型组阳性率(48.1%、85.2%和77.8%)。Vimentin和VEGF-C的免疫阳性表达强度在乳头状癌中高于滤泡癌,CK-19和COX-2在乳头状癌和滤泡癌中的表达相近。四种免疫学指标的免疫阳性强度在乳头状癌原发灶、转移灶、滤泡癌高分化组、低分化型组间均无明显差异。乳头状癌中CK-19与Vimentin间免疫表达强度无相关性,VEGF-C和COX-2间呈正相关关系。结论:综合检测CK-19、Vimentin、VEGF-C和COX-2四种免疫学指标,对探讨甲状腺乳头状癌和滤泡癌分化、浸润、转移和预后评估具有一定的参考价值。 Objective: To study the correlations among the expression levels of cytokeratin-19 (CK-19), vimentin, vascular endothelial growth factor-C (VEGF-C) and cyclooxygenase-2 (COX-2) and the differentiation, invasiveness and metastatic potential in papillary and follicular thyroid carcinomas (FTC). Methods: Immunohistochemical SP method was used to assess the expression of CK-19, vimentin, VEGF-C and COX-2 in the 94 cases of papillary thyroid carcinoma (PTC) and 54 cases of FTC enrolled in our study. Results: CK-19, VEGF-C and COX-2 were expressed in the cytoplasm of tumor cells. Vimentin was expressed both in the mesenchyma and in the cytoplasm of tumor cells. Differences in expression were analyzed statistically using the positive rate and expression intensity. The positive rate of CK-19 was significantly higher in PTC (90.4%) than in FTC (61.1%). The positive rates of vimentin, VEGF-C and COX-2 in PTC (100%, 86.2% and 81.9%, respectively) were similar to those in FTC (100%, 87.0% and 81.5%, respectively). The expression rates of the four pro- teins in PTC with and without lymph node metastasis (including the primary foci and metastatic lesions) were also similar to each other. Except for the positive rates of vimentin expression, both 100% in the two differentiation types of FTC, the ex- pression rates of CK-19, VEGF-C and COX-2 were higher in well-differentiated FTC (74.1%, 88.9% and 85.2%) than in poorly differentiated FTC (48.1%, 85.2% and 77.8%). The expression intensities of vimentin and VEGF-C in PTC were sig- nificantly higher than those in FTC. The expression intensities of CK-19 and COX-2 in PTC were similar to those in FTC. No significant difference was found in PTC between cases with and without metastasis, and no significant difference was found in FTC between the well-differentiated cases and the poorly differentiated cases. There is a positive correlation be- tween the expression intensity of VEGF-C and COX-2 in PTC, but not between the expression of CK-19 and vimentin. Conclusion: Immunohistochemical detection of CK-19, vimentin, VEGF-C and COX-2 expression may carry clinical significance in evaluating the degree of differentiation, invasiveness, metastatic potential, and prognosis of papillary thyroid carcinoma and follicular thyroid carcinoma.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2010年第20期1161-1165,共5页 Chinese Journal of Clinical Oncology
关键词 甲状腺乳头状癌 甲状腺滤泡癌 CK-19 Vimentin VEGF-C COX-2 Papillary thyroid carcinoma Follicular thyroid carcinoma CK-19 Vimentin VEGF-C COX-2
  • 相关文献

参考文献16

  • 1DeLellis RA,Lloyd RV,Heitz PV,et al.World Health Organization Classification of tumours.Pathology and genetics tumours of endocrine organs[M].Lyon:IARC Press,2004:51-80.
  • 2Masi L,Malentacchi G,Campanacci D,et al.Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone[J].Virchows Arch,2002,440(5):491-497.
  • 3李颖,江昌新,谭郁彬,徐嵩,夏睿.甲状腺恶性肿瘤病理诊断率的变化——天津医科大学总医院27年病理资料分析[J].中华内分泌代谢杂志,2006,22(2):105-109. 被引量:12
  • 4Laco J,Ryska A,Cap J,et al.Expression of galectin-3,cytokeratin19,neural cell adhesion molecule and E-cadhedrin in certain variants of papillary thyroid carcinoma[J].Cesk Patol,2008,44(4):103-107.
  • 5Alix-Panabieres C,Vendrell JP,Slijper M,et al.Full-length cytokeratin-19 is released by human tumor cells:a potential role in metastadc progression of breast cancer[J].Breast Cancer Res,2009,11(3):R39.
  • 6Kalluri R,Weinberg RA.The basics of epithelial-mesenchymal transition[J].J Clin Invest,2009,119(6):1420-1428.
  • 7Vasko V,Espinosa AV,Scouten W,et al.Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion[J].Proc Nad Acad Sci U S A,2007,104(8):2803-2808.
  • 8Henzen-Logmans SC,Mullink H,Ramaekers FC,et al.Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue[J].Virchows Arch A Pathol Anat Histopathol,1987,410(4):347-354.
  • 9Lohela M,Bry M,Tammela T,et al.VEGFs and receptors involved in angiogenesis versus lymphangiogenesis[J].Gurr Opin Cell Biol,2009,21(2):154-165.
  • 10Tian X,Cong M,Zhou W,et al.Relationship between protein expression of VEGF-C,MMP-2 and lymph node metastasis in papilhry thyroid cancer[J].J hat Med Res,2008,36(4):699-703.

二级参考文献34

  • 1白耀.甲状腺恶性肿瘤诊断和治疗的热点讨论[J].中华内分泌代谢杂志,2004,20(4):283-286. 被引量:19
  • 2李颖,江昌新,谭郁彬,徐嵩,夏睿.甲状腺恶性肿瘤病理诊断率的变化——天津医科大学总医院27年病理资料分析[J].中华内分泌代谢杂志,2006,22(2):105-109. 被引量:12
  • 3DeLeUis RA, Lloyd RV, Heitz PV, et al. World Health Organization classification of tumours. Pathology and genetics tumours of endocrine organs. Lyon : IARC Press,2004 : 51-80.
  • 4Masi L, Malentaechi C, Campanaeci D, et al. Transforming growth factor-β isoform and receptor expression in chondrosareoma of bone. Virchows Arch,2002,440 (5) :491-497.
  • 5Pelizzo MR, Merante BI, Toniato A, et al. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma. Minerva Endocrinol,2008,33 (4) :359-379.
  • 6Hojilla CV, Mohammed FF, Khokha R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer,2003,89 (10) : 1817-1821.
  • 7Fan SQ,Wei QY,Li MR,et al. Expression and clinical significance of MMP-2, MMP-9, TIMP-1 and MMP-2 in breast carcinoma. Cancer, 2003,22 ( 9 ) : 968 -973.
  • 8Nakamura H, Ueno H, Yamashita K, et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metallopreteinase in human papillary thyroid carcinomas. Cancer Res, 1999, 59(2) :467-473.
  • 9Kraiem Z, Korem S. Matrix metalloproteinases and the thyroid. Thyroid, 2000,10(12) :1061-1069.
  • 10Khasigov PZ, Podobed OV, Gracheva T, et al. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis. Biochemistry (Mosc) ,2003,68 (7) :711-717.

共引文献15

同被引文献42

  • 1赵惠柳,黄文成,黄昭东,刘志民.肿瘤标记物CYFRA21-1诊断鼻咽癌的临床价值研究[J].现代肿瘤医学,2004,12(4):289-290. 被引量:14
  • 2江昌新,谭郁彬.桥本甲状腺炎与亚急性甲状腺炎的免疫组织学变化[J].中华内分泌代谢杂志,1996,12(3):147-149. 被引量:16
  • 3Masi L,Malentacchi C,Campanacci D,et al.Transforming growth factor-isoform and receptor expression in chondrosarcoma of bone.Virchows Arch,2002,440:491-497.
  • 4Prasad ML,Pellegata NS,Huang Y,et al.Galectin-3,fibronectin-1,CITED-1,HBME1,and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.Modern Pathology,2005:48-57.
  • 5Flanagan JN,Pineda P,Knapp PE,et al.Expression of eytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction.Endocr Pract,2008,14:168-174.
  • 6Bonzanini M,Amadori PL,Sagrumoso C,et al.Expression of cytokeratin 19 and protein p63 in fine needle aspiration biopsy of papillary thyroid carcinoma.Acta Cytol,2008,52:.541-548.
  • 7Ivaska J,Pallari HM,Navo J,et al.Novel function of vimentin in cell adhesion,migration and signaling.Exp Cell Res,2007,313:2050-2062.
  • 8Zamoner A,Barreto KP,Danilo WF,et al.Hyperthyroidism in the developing rat testis is associated with oxidative stress and hyperphosphorylated vimentin accumulation.Mol Cell Endocrinol,2007,67:116-126.
  • 9Miettinen M,Franssila K,Lehto VP,et al.Expression of intermediate filament proteins in thyroid gland and thyroid tumors.Lab Invest,1984,50:262-270.
  • 10Henzen-Lognans SC,Mullink H,Ramaekers FC,et al.Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue.Virchows Arch A Pathol Anat Histopathol,1987,410:347-354.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部